Thomas Miller

Chief Executive Officer at Iambic Therapeutics.

Earliest Form D on file: Apr 2026

Filed Apr 8, 2026

Iambic Therapeutics

AI drug design with automated synthesis and testing

Biotech, San Diego CA

Signed as Chief Executive Officer

$27.8M

sold of $50M offered

Network

At Iambic Therapeutics

11 people

Fred Manby
Executive Officer, Director
Evan Rachlin
Director
Jishnu Bhattacharjee
Director
Kurt von Emster
Director
Mary Tagliaferri
Director
Michael Secora
Executive Officer

5 more at Iambic Therapeutics